CRL Charles River
- 217.210
- -0.340-0.16%
- 217.210
- 0.0000.00%
Charles River News
Charles River (CRL) Banks on RMS Growth Amid Competition
Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Today we're going to take a look at the well-established Charles River Laboratories International, Inc. (NYSE:CRL). The company's stock saw significant share price movement during recent months on
Charles River(CRL.US) Director Sells US$78,225.37 in Common Stock
$Charles River(CRL.US)$ Director MASSARO GEORGE sold 332 shares of common stock on May 15, 2024 at an average price of $235.62 for a total value of $78,225.37.Source: Announcement What is statement of
Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
Charles River(CRL.US) Officer Sells US$295.97K in Common Stock
$Charles River(CRL.US)$ Officer LaPlume Joseph W sold 1,304 shares of common stock on May 10, 2024 at an average price of $226.97 for a total value of $295.97K.Source: Announcement What is statement o
Charles River Labs Price Target Cut to $228.00/Share From $260.00 by TD Cowen
Charles River Labs Price Target Cut to $228.00/Share From $260.00 by TD Cowen
Charles River Labs Is Maintained at Hold by TD Cowen
Charles River Labs Is Maintained at Hold by TD Cowen
TD Cowen: Maintaining the Charles River (CRL.US) rating, adjusted from holding to holding rating, and adjusted the target price from $260.00 to $228.00.
TD Cowen: Maintaining the Charles River (CRL.US) rating, adjusted from holding to holding rating, and adjusted the target price from $260.00 to $228.00.
Don't Overlook Charles River (CRL) International Revenue Trends While Assessing the Stock
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260
Charles River Laboratories International (CRL) has an average outperform rating and a price target range of $226 to $300, according to analysts polled by Capital IQ.
Charles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market Uncertainties
Form 144 | Charles River(CRL.US) Officer Proposes to Sell 300K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $Charles River(CRL.US)$ Officer Joseph LaPlume intends to sell 1,304 shares of its common stock on May 10, with a total market value of approximately $300K. Joseph La
Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)
Charles River Labs Is Maintained at Outperform by Baird
Charles River Labs Is Maintained at Outperform by Baird
Charles River Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 17.35% Baird $282 → $270 Maintains Outperform 03/18/2024 26.04% Argus Research $240 → $290 Main
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282
Charles River Laboratories International (CRL) has an average rating of outperform and price targets ranging from $226 to $300, according to analysts polled by Capital IQ.
Buy Rating on Charles River Labs Amidst Solid Q1 Performance and Positive Market Outlook
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
Charles River Laboratories International Files Automatic Mixed Shelf
Earnings Call Summary | Charles River(CRL.US) Q1 2024 Earnings Conference
The following is a summary of the Charles River Laboratories International, Inc. (CRL) Q1 2024 Earnings Call Transcript:Financial Performance:Charles River Laboratories reported Q1 2024 revenue of $1.
Analysis
Price Target
No Data
